<DOC>
	<DOCNO>NCT02659865</DOCNO>
	<brief_summary>The main purpose study investigate safety study drug know LY3039478 evaluate two different formulation LY3039478 healthy participant . Part A three period . Either LY3039478 placebo give mouth period . Part B two period . Participants receive formulation LY3039478 , mouth , course study . Both part study also explore much LY3039478 get bloodstream long take body get rid . Information side effect also collect . Participants may enroll one part . The study last least 33 day , include screen . Screening must perform 30 day enrollment . Part B add protocol amendment approve April , 2016 .</brief_summary>
	<brief_title>A Study LY3039478 Healthy Participants</brief_title>
	<detailed_description />
	<criteria>Body mass index ( BMI ) 18 32 kilogram per meter square ( kg/mÂ² ) Known allergy LY3039478 , related compound component formulation Have previously receive LY3039478 Smokers stop smoke less 3 month ago</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>